Kiselak Tomas
Visual SEC Form 4 history across 2 companies, 9 transactions and 2 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
No latest transaction fact is available.
No open-market insider purchase is available.
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| APGE | Kiselak Tomas | DIR | return | 7.65k | — | D | 0.0% | 09/03 | 09/03 | |
| APGE | Kiselak Tomas | DIR | return | 14.4k | — | D | 0.0% | 09/03 | 09/03 | |
| APGE | Kiselak Tomas | DIR | return | 10.3k | — | D | 0.0% | 09/03 | 09/03 | |
| APGE | Kiselak Tomas | DIR | return | 47.7k | — | D | 0.0% | 09/03 | 09/03 | |
| APGE | Kiselak Tomas | DIR | return | 6.74M | — | D | 0.0% | 09/03 | 09/03 | |
| APGE | Kiselak Tomas | DIR | return | 51.1k | — | D | — | 0.0% | 09/03 | 09/03 |
| APGE | Kiselak Tomas | DIR | return | 51.1k | — | D | — | 0.0% | 09/03 | 09/03 |
| APGE | Kiselak Tomas | DIR | return | 340k | — | D | — | 0.0% | 09/03 | 09/03 |
| SYRE | Kiselak Tomas | DIR | grant | 8.02k | $0 | A | +48.0% | 05/29 | 05/27 |
Kiselak Tomas Insider Activity FAQ
SEC Form 4 context
Who is Kiselak Tomas?
Kiselak Tomas is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001830177.
Which companies has Kiselak Tomas reported transactions for?
Apogee Therapeutics, Inc., Spyre Therapeutics, Inc.
When was Kiselak Tomas's latest insider buy?
No open-market insider purchase is available for this period.
When was Kiselak Tomas's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.